RespireRx Pharmaceuticals Inc (RSPI)

[drfreely]

Manuso and the board have put into place extremely large placement fees for any investor crazy enough to cut a check: approx 15 cents on every dollar. Not to mention huge stock options for all.
Plus they owe money to landlords, attorneys, creditors, past management. How does an investor know that their money will go to trials and not those past obligations.
If their ampa patents were so great, why did their past partners let them go for a song and a dance.
Why did DARPA pass on ampakines?
If the FDA now admits the artifact issue in the Acute Dosing portion of the safety trial was due to the slide preparation, why aren't investors crawling out the woodwork to plow money into ampa trials?
As for Dronibinol, why mess around with a Schedule One menace to American Society, when you can buy stock in Aurora Cannabis, and Canopy in Canada where the government is your partner, not your enemy? Until congress acts, there will be no further indications approved for Dronibinol. Period.
Finally, as I've said before, good local plumbing companies have more money in the bank than RSPI, and you cannot run trials without it no matter how good your conference slide show looks and sounds.